Dexamethasone Treatment for COVID-19-Related Lung Injury in an Adult with WHIM Syndrome

J Clin Immunol. 2022 Feb;42(2):270-273. doi: 10.1007/s10875-021-01185-2. Epub 2021 Dec 1.

Authors

Daigo Akahane¹, Shunsuke Otsuki², Daisuke Hasegwa³, Hidehiro Watanabe⁴, Akihiko Gotoh²

Affiliations

¹ Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. daigoakahane@msn.com.
² Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
³ Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan.
⁴ Department of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo, Japan.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
COVID-19 / complications*
COVID-19 Drug Treatment*
Dexamethasone / therapeutic use*
Humans
Lung Injury / drug therapy*
Lung Injury / etiology*
Male
Primary Immunodeficiency Diseases / drug therapy*
Warts / drug therapy*

Substances

Dexamethasone

Supplementary concepts

WHIM syndrome